|Day Low/High||203.20 / 208.00|
|52 Wk Low/High||150.37 / 228.91|
Jim Cramer weighs in on Nvidia, Advanced Micro Devices, Constellation Brands, Bausch Health, Arista Networks, Gilead Sciences and more.
The company has spent a lot of time and money trying to meet the supply needs of the recreational cannabis market.
A pair of earnings report this week will shed light on the future direction of two fast-growing companies in very different fields.
Cannabis' non-psychoactive derivative could disrupt the CPG (Consumer Product Group) space very soon. Watch the video for the more on the opportunities and challenges.
Oh, by the way, Constellation, for those who've forgotten, holds a 38% stake in Canopy Growth.
There is certainly too much to ignore about STZ for the majority of analysts.
Boston Beer stock loses its fizz after receiving a downgrade from Goldman Sachs.
Jim Cramer warns: Don't blink or you'll miss this market movement. He looks at what's got investors' attention: Boeing, China, retailers and rotations.
China's top trade negotiator is expected to meet with President Donald Trump in the White House later Thursday.
The consumer is alive, well, and might benefit from a thaw with China and easy to get jobs. So would Boeing and Caterpillar.
Curious about how you should trade Constellation Brands after it announced earnings? Here's what Real Money's Stephen Guilfoyle has to say.
What I do know is that TSLA now faces a tumultuous uphill battle in order to meet its full year guidance.
Constellation Brands posts stronger-than-expected fourth-quarter earnings after selling its low-end wine brand portfolio for around $1.7 billion.
Most of the wine brands being sold by Constellation Brands cost around $11 a bottle.
I am upping my Apple price target.
Global stocks paused Thursday, with Asia snapping a five-day winning streak, as investors assessed reports of progress in U.S. China trade talks and worryingly weak economic data from German that continues to raise concerns of worldwide manufacturing recession.
U.S. stock futures are mixed as investors assess reports of progress in U.S.-China trade talks and weak economic data from Germany; Tesla slides after its first-quarter production and delivery figures missed estimates; Ethiopia says pilots followed proper procedures in Boeing 737 MAX 8 crash.
What to look for when Dave & Buster's and Constellation Brands report results.
The biggest IPO of the year so far is likely to set a trend, Jim Cramer says.
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
Plus, why investors should care about the yield curve, and a closer look at Tilray's quarter.
Jim Cramer said that he believes that Canopy Growth could be the next Amazon. Here's why he thinks that the cannabis company could be the next Amazon.
The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.
Assessing Aurora and its peers, strictly on the numbers.
In this day and age, companies must be 'disruptors' or get left in the dust.
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
In its first report on cannabis companies, Melius says prices are high.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.